PRIA, Government Policy, Made Personal

Summary

Within 4 years after October 24, 2018, and every 4 years after that, the Comptroller General must audit the Office and certain programs, including the High Intensity Drug Trafficking Areas Program, the Drug-Free Communities Program, and the campaign under section 1708(f). The Comptroller General must then send a report to the Director and the proper congressional committees that reviews the programs’ policies and activities, checks how economically, efficiently, and effectively they are run, and recommends any policy or management changes needed to prevent and detect fraud and abuse.

Title 21, §1715

Food and Drugs, Source: USLM XML via OLRC

Not later than 4 years after October 24, 2018, and every 4 years thereafter, the Comptroller General of the United States shall—

(1)conduct an audit relating to the programs and operations of—

(A)the Office; and

(B)certain programs within the Office,1 including—

(i)the High Intensity Drug Trafficking Areas Program;

(ii)the Drug-Free Communities Program; and

(iii)the campaign under section 1708(f) of this title; and

(2)submit to the Director 1 and the appropriate congressional committees 1 a report containing an evaluation of and recommendations on the—

(A)policies and activities of the programs and operations subject to the audit;

(B)economy, efficiency, and effectiveness in the administration of the reviewed programs and operations; and

(C)policy or management changes needed to prevent and detect fraud and abuse in such programs and operations.

Notes & Related Subsidiaries

Editorial Notes

References in Text

The terms “Office”, “Director”, and “appropriate congressional committees”, referred to in text, probably have the meanings given such terms in section 1701 of this title. Codification Section was enacted as part of the Substance Abuse Prevention Act of 2018, and also as part of the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT for Patients and Communities Act, and not as part of the Office of National Drug Control Policy Reauthorization Act of 1998 which comprises this chapter.

§1715 Gao Audit

Summary

Title 21, §1715

Notes & Related Subsidiaries

Editorial Notes

References in Text

Citations & Metadata